Cross-cultural Adaptation, Reliability and Validity of the Turkish Version of the Headache Disability Questionnaire
Launched by GAZI UNIVERSITY · Jan 30, 2021
Trial Information
Current as of May 11, 2025
Completed
Keywords
ClinConnect Summary
This clinical trial is focused on adapting and testing a questionnaire called the Headache Disability Questionnaire (HDQ) for Turkish speakers. The HDQ helps doctors understand how headaches affect people's daily lives. The researchers want to make sure the Turkish version of this questionnaire is reliable (consistent results) and valid (measures what it’s supposed to measure).
If you or a family member have been diagnosed with any type of chronic headache, you may be eligible to participate in this study. However, individuals with cognitive or neurological disorders will not be included. Participants can expect to fill out the questionnaire and provide feedback, helping to improve headache care for others in the Turkish-speaking community. The study is currently recruiting participants aged 18 and older and aims to ensure that the questionnaire accurately reflects the experiences of those with headaches.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosed with any type of headache,
- • Have a chronic headache.
- Exclusion Criteria:
- • Having a cognitive and neurological disorder.
About Gazi University
Gazi University, a leading research institution based in Ankara, Turkey, is committed to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university integrates cutting-edge research with clinical practice to explore new therapeutic approaches and enhance existing treatments. Gazi University adheres to the highest ethical standards and regulatory guidelines, ensuring the integrity and safety of its clinical trials. By fostering partnerships with healthcare professionals and academic institutions, Gazi University aims to contribute significantly to the global scientific community and address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, None Selected, Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials